Search Results - Farr AM
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US by Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book